Literature DB >> 2492366

Pneumococcal polysaccharide vaccine.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492366

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  28 in total

1.  Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.

Authors:  A H Tu; R L Fulgham; M A McCrory; D E Briles; A J Szalai
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 2.  Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors:  Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

3.  Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections.

Authors:  W J Hueston; A G Mainous; N Brauer
Journal:  J Community Health       Date:  2000-02

Review 4.  The value of influenza and pneumococcal vaccines in the elderly.

Authors:  A S Monto; M S Terpenning
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

Review 5.  Prevention of lung infections associated with human immunodeficiency virus infection.

Authors:  P C Hopewell
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

6.  Pneumococcal immunizations at flu clinics: the impact of community-wide outreach.

Authors:  D Shenson; J Quinley; D DiMartino; P Stumpf; M Caldwell; T Lee
Journal:  J Community Health       Date:  2001-06

7.  Overwhelming postsplenectomy infection.

Authors:  M L Brigden
Journal:  West J Med       Date:  1993-03

8.  Influenza and pneumococcal vaccination in the emergency department: is it feasible?

Authors:  K Wrenn; M Zeldin; O Miller
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

9.  A strategy to improve the utilization of pneumococcal vaccine.

Authors:  C M Clancy; D Gelfman; R M Poses
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

10.  SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.